Vertex to Cease Clinical Trials on Diabetes Treatment
Vertex Pharmaceuticals will not advance clinical trials of a treatment for Type 1 diabetes after efficacy data failed to support further clinical advancement.
Prefilled Syringes Market Size to Reach US$ 15.00 Billion by 2030, Driven by Increasing Prevalence of Chronic Diseases - The Insight Partners
The global prefilled syringes market share is projected to grow from US$ 6.69 Billion in 2022 to US$ 15.0 Billion by 2030, ...
European committee says Lilly Alzheimer’s drug shouldn’t get marketing approval
A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...
inews.co.uk14h
The future of weight loss drugs: gummies, tablets and melt-in-the-mouth strips
The race is on to make the first oral weight loss medicines, but smaller US pharmacies may have already got there – if they ...
The Tony’s Chocolonely Effect: Upstart Brands Are Gobbling Up Big Food’s Market Share
Consumers have developed a taste for fresh brands, such as Chocolonely chocolate bars, Poppi soda, and Lesser Evil popcorn.
Tariff treatment: Six diagnoses for EU pharma sector amid US trade war
Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.